CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0803

BPC-157 Capsule

Filed under Oral Tablets. The bureau holds 116 laboratory returns for this compound from 40 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

40 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760 A 7 10.0 9.9 10.0 21 May 2026 21 May 2026
Kerui PeptidesCASE #VI-2026-0626 A 4 10.0 9.9 10.0 19 Mar 2026 8 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 4 10.0 10.0 10.0 20 Jan 2026 5 Jun 2026
WuXi TIDESCASE #VI-2026-0335 A 4 10.0 9.9 10.0 28 Apr 2026 17 Jul 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 3 10.0 10.0 10.0 18 Feb 2026 5 Jul 2026
QYAOBIOCASE #VI-2026-0861 A 3 10.0 9.9 10.0 12 May 2026 8 Jul 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 3 10.0 9.9 10.0 8 Mar 2026 3 Jul 2026
AsymchemCASE #VI-2026-0091 A 3 10.0 10.0 10.0 16 Jun 2026 14 Jul 2026
Sangon BioCASE #VI-2026-0671 A 2 10.0 10.0 10.0 3 Mar 2026 15 Apr 2026
JEEP PeptidesCASE #VI-2026-0457 A 2 10.0 10.0 10.0 15 Apr 2026 21 Jun 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 10.0 10.0 10.0 21 Feb 2026 12 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 2 10.0 10.0 10.0 9 Dec 2025 16 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 10.0 10.0 10.0 28 May 2026 9 Jun 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 5 9.9 9.9 10.0 14 Nov 2025 16 Apr 2026
Sigma-AldrichCASE #VI-2026-0829 A 4 9.9 9.9 10.0 1 Apr 2026 27 Jun 2026
PolyPeptide GroupCASE #VI-2026-0143 A 4 9.9 9.9 10.0 3 Apr 2026 16 Aug 2026
Hubei JianxiangCASE #VI-2026-0048 A 3 9.9 9.9 10.0 20 Mar 2026 11 Jun 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 3 9.9 9.9 10.0 5 Apr 2026 1 Jun 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 9.9 9.9 9.9 8 Apr 2026 22 Jul 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 9.9 9.9 10.0 12 Apr 2026 27 Jul 2026
BachemCASE #VI-2026-0314 A 2 9.9 9.9 10.0 15 Mar 2026 17 May 2026
SinoPepCASE #VI-2026-0387 A 2 9.9 9.9 9.9 10 Dec 2025 24 May 2026
AmbioPharmCASE #VI-2026-0177 A 2 9.9 9.9 10.0 15 Jun 2026 3 Aug 2026
Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 X 1 9.3 9.3 9.3 25 Apr 2025 25 Apr 2025
Glbiochem (Shanghai)CASE #VI-2026-0704 A 2 9.1 8.4 9.8 24 May 2026 24 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 2 8.9 7.9 10.0 24 May 2026 24 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 7 8.8 7.8 9.7 25 May 2026 25 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 4 8.7 8.1 9.5 24 May 2026 24 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 8 8.2 6.9 9.4 21 May 2026 21 May 2026
Risynth BioCASE #VI-2026-0672 X 1 8.2 8.2 8.2 9 Jun 2025 9 Jun 2025
Lisa BiopeptideCASE #VI-2026-0131 X 1 7.9 7.9 7.9 27 Feb 2025 27 Feb 2025
Precision Peptide CoCASE #VI-2026-0559 X 2 7.6 5.6 9.7 2 Jul 2025 17 May 2026
Heman Peptide HMCASE #VI-2026-0089 X 2 7.4 7.4 7.4 7 May 2025 24 May 2026
NextGen HealthCASE #VI-2026-0604 X 1 7.1 7.1 7.1 13 Feb 2025 13 Feb 2025
M-PeptidesCASE #VI-2026-0442 X 1 7.1 7.1 7.1 25 Apr 2025 25 Apr 2025
Qing Li PeptideCASE #VI-2026-0469 X 8 6.6 3.2 8.2 21 May 2025 24 May 2026
Haikou Mingheng BiotechnologyCASE #VI-2026-0126 X 1 6.5 6.5 6.5 3 Jun 2025 3 Jun 2025
Evolve BioPepCASE #VI-2026-0755 X 1 6.4 6.4 6.4 13 Jun 2025 13 Jun 2025
Peptide ArkCASE #VI-2026-0350 X 1 1.9 1.9 1.9 8 Jul 2025 8 Jul 2025
PepKitsCASE #VI-2026-0320 X 1 0.0 0.0 0.0 27 Feb 2025 27 Feb 2025

Open any subject to view the batch-level evidence for BPC-157 Capsule alone.